Induction of a CD8+ cytotoxic T lymphocyte response by cross-priming requires cognate CD4+ T cell help

Journal of Experimental Medicine

Volumn 186, Issue 1, 1997, Pages 65-70

  Bennett, Sally R M ^a,b   Carbone, Francis R ^c   Karamalis, Freda ^a,b   Miller, Jacques F A P ^a   Heath, William R ^a  

^a ROYAL MELBOURNE HOSPITAL   (Australia)

^b ROYAL BRISBANE AND WOMEN'S HOSPITAL   (Australia)

^c ALFRED HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL CELL; ANTIGEN PRESENTING CELL; ARTICLE; CELLULAR IMMUNITY; CYTOTOXIC T LYMPHOCYTE; EFFECTOR CELL; FLOW CYTOMETRY; HELPER CELL; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE SUBPOPULATION; TARGET CELL;

ANIMALS; ANTIGEN PRESENTATION; CD8-POSITIVE T-LYMPHOCYTES; CELL COMMUNICATION; HISTOCOMPATIBILITY ANTIGENS CLASS I; IMMUNITY, CELLULAR; MICE; OVALBUMIN; T-LYMPHOCYTES, HELPER-INDUCER;

EID: 0030848161     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.186.1.65     Document Type: Article

References (31)

1. Moore, M.W., F.R. Carbone, and M.J. Sevan. 1988. Introduction of soluble protein into the class I pathway of antigen processing and presentation. Cell. 54:777-785.
2. Bevan, M.J. 1976. Cross-priming for a secondary cytotoxic response to minor H antigens with H-2 congenic cells which do not cross-react in the cytotoxic assay. J. Exp. Med. 143: 1283-1288.
3. Gooding, L.R., and C.B. Edwards. 1980. H-2 antigen requirements in the in vitro induction of SV40-specific cytotoxic T lymphocytes. J. Immunol. 124:1258-1262.
4. Carbone, F.R., and M.J. Bevan. 1990. Class I-restricted processing and presentation of exogenous cell-associated antigen in vivo. J. Exp. Med. 171:377-387.
5. Huang, A.Y., P. Golumbek, M. Ahmadzadeh, E. Jaffee, D. Pardoll, and H. Levitsky. 1994. Role of bone marrow-derived cells in presenting MHC class I-restncted tumor antigens. Science (Wash. DC). 264:961-965.
6. Bevan, M.J. 1989. Immunology. Stimulating killer cells. Nature (Lond.). 342:478-479.
7. von Boehmer, H., and K. Hafen. 1986. Minor but not major histocompatibility antigens of thymus epithelium tolerize precursors of cytolytic T cells. Nature (Lond.). 320:626-628.
8. Kurts, C., W.R. Heath, F.R. Carbone, J. Allison, J.F.A.P. Miller, and H. Kosaka. 1996. Constitutive class I-restricted exogenous presentation of self antigens in vivo. J. Exp. Med. 184:923-930.
9. Gosgrove, D., D. Gray, A. Dierich, J. Kaufman, M. Lemeur, C. Benoist, and D. Mathis. 1991. Mice lacking MHC class II molecules. Cell. 66:1051-1066.
10. Blanas, E., F.R. Carbone, J. Allison, J.F.A.P. Miller, and W.R. Heath. 1996. Induction of autoimmune diabetes by oral administration of autoantigen. Science (Wash. DC). 274: 1707-1709.
11. Heath, W.R., J. Allison, M.W. Hoffmann, G. Schonrich, G. Hammerling, B. Arnold, and J.F.A.P. Miller. 1992. Autoimmune diabetes as a consequence of locally produced interleukin-2. Nature (Lond.). 359:547-549.
12. Nikolic-Zugic, J., and M.J. Bevan. 1990. Role of self-peptides in positively selecting the T-cell repertoire. Nature (Lond.). 344:65-67.
13. Debrick, J.E., P.A. Campbell, and U.D. Staerz. 1991. Macrophages as accessory cells for class I MHC-restricted immune responses. J. Immunol. 147:2846-2851.
14. Husmann, L.A., and M.J. Bevan. 1988. Cooperation between helper T cells and cytotoxic T lymphocyte precursors. Ann. NY Acad. Sci. 532:158-169.
15. Guerder, S., and P. Matzinger. 1992. A fail-safe mechanism for maintaining self-tolerance. J. Exp. Med. 176:553-564.
16. + cells are essential for allorejection. J. Exp. Med. 184:2013-2018.
17. + T helper cell function in vivo: differential requirement for induction of antiviral cytotoxic T-cell and antibody responses. J. Virol. 62: 2102-2106.
18. + T cell subsets in the control of an acute herpes simplex virus infection of the skin and nervous system. J. Gen. Virol. 68:825-833.
19. Buller, R.M., K.L. Holmes, A. Hugin, T.N. Frederickson, and H.C. Morse III. 1987. Induction of cytotoxic T-cell responses in vivo in the absence of CD4 helper cells. Nature (Lond.). 328:77-79.
20. + T cells. Immunol. Cell Biol. 67:413-420.
21. von Herrath, M.G., M. Yokoyama, J. Dockter, M.B.A. Oldstone, and J.L. Whitton. 1996. CD4-deficient mice have reduced levels of memory cytotoxic T lymphocytes after immunization and show diminished resistance to subsequent virus challenge. J. Virol. 70:1072-1079.
22. + T cells. J. Exp. Med. 184:863-871.
23. Keene, J.A., and J. Forman. 1982. Helper activity is required for the in vivo generation of cytotoxic T lymphocytes. J. Exp. Med. 155:768-782.
24. Cassell, D., and J. Forman. 1988. Linked recognition of helper and cytotoxic antigenic determinants for the generation of cytotoxic T lymphocytes. Ann. NY Acad. Sci. 532:51-60.
25. Juretic, A., B. Malenica, E. Juretic, J. Klein, and Z.A. Nagy. 1985. Helper effects required during in vivo priming tor a cytolytic response to the H-Y antigen in nonresponder mice. J. Immunol. 134:1408-1414.
26. Mitchison, N.A., and C. O'Malley. 1987. Three-cell-type clusters of T cells with antigen-presenting cells best explain the epitope linkage and noncognate requirements of the in vivo cytolytic response. Eur. J. Immunol. 17:1579-1583.
27. Rock, K.L. 1996. A new foreign policy: MHC class I molecules monitor the outside world. Immunol. Today 17:131-137.
28. + CTL in vivo with peptide vaccine constructs. J. Immunol. 152:549-556.
29. + T cells. J. Exp. Med. In press.
30. Jondel, M., R. Schirmbeck, and J. Reimann. 1996. MHC class I-restricted CTL responses to exogenous antigens. Immunity. 5:295-302.
31. Carbone, F.R., and M.J. Bevan. 1989. Induction of ovalbumin-specific cytotoxic T cells by in vivo peptide immunization. J. Exp. Med. 169:603-612.